Concepedia

Anders Fuglsang

AF

Statistics

Publications

10

Citations

479

H-Index

10

Active since

2003

Affiliations

University of Copenhagen(Current)

Novo Nordisk Foundation

Chr. Hansen (Denmark)

Novo Nordisk (Denmark)

MRC Laboratory of Molecular Biology

Anders Fuglsang is an author at University of Copenhagen specializing in life sciences, molecular biology, and structural biology.

ORCID

Publications per year

2003–2024

10

Publications

10

Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo

Anders Fuglsang, Fergal P. Rattray, Dan‐Eric Nilsson et al. · Antonie van Leeuwenhoek · 2003 · 154 citations

, , +7

Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas

Nicholas Sofos, Mingxia Feng, Stefano Stella et al. · Molecular Cell · 2020 · 63 citations · Full text

, , +10

Retron-Eco1 assembles NAD+-hydrolyzing filaments that provide immunity against bacteriophages

Arturo Carabias, Sarah Camara-Wilpert, Mario Rodríguez Mestre et al. · Molecular Cell · 2024 · 51 citations · Full text

, , +10

Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3

Arturo Carabias, Anders Fuglsang, Piero Temperini et al. · Nature Communications · 2021 · 48 citations · Full text

, , +13

Characterization of New Milk-derived Inhibitors of Angiotensin Converting Enzyme<i>In Vitro</i>and<i>In Vivo</i>

Anders Fuglsang, Dan‐Eric Nilsson, Niels C. Berg Nyborg · Journal of Enzyme Inhibition and Medicinal Chemistry · 2003 · 45 citations

, , +15

1–5 of 10